Literature DB >> 22037357

Surfactant protein B inhibits secretory phospholipase A2 hydrolysis of surfactant phospholipids.

R Duncan Hite1, Bonnie L Grier, B Moseley Waite, Ruud A Veldhuizen, Fred Possmayer, Li-Juan Yao, Michael C Seeds.   

Abstract

Hydrolysis of surfactant phospholipids (PL) by secretory phospholipases A(2) (sPLA(2)) contributes to surfactant damage in inflammatory airway diseases such as acute lung injury/acute respiratory distress syndrome. We and others have reported that each sPLA(2) exhibits specificity in hydrolyzing different PLs in pulmonary surfactant and that the presence of hydrophilic surfactant protein A (SP-A) alters sPLA(2)-mediated hydrolysis. This report tests the hypothesis that hydrophobic SP-B also inhibits sPLA(2)-mediated surfactant hydrolysis. Three surfactant preparations were used containing varied amounts of SP-B and radiolabeled tracers of phosphatidylcholine (PC) or phosphatidylglycerol (PG): 1) washed ovine surfactant (OS) (pre- and postorganic extraction) compared with Survanta (protein poor), 2) Survanta supplemented with purified bovine SP-B (1-5%, wt/wt), and 3) a mixture of dipalmitoylphosphatidylcholine (DPPC), 1-palmitoyl-2-oleoyl-phosphatidylcholine (POPC), and 1-palmitoyl-2-oleoyl-phosphatidylglycerol (POPG) (DPPC:POPC:POPG, 40:40:20) prepared as vesicles and monomolecular films in the presence or absence of SP-B. Hydrolysis of PG and PC by Group IB sPLA(2) (PLA2G1A) was significantly lower in the extracted OS, which contains SP-B, compared with Survanta (P = 0.005), which is SP-B poor. Hydrolysis of PG and PC in nonextracted OS, which contains all SPs, was lower than both Survanta and extracted OS. When Survanta was supplemented with 1% SP-B, PG and PC hydrolysis by PLA2G1B was significantly lower (P < 0.001) than in Survanta alone. When supplemented into pure lipid vesicles and monomolecular films composed of PG and PC mixtures, SP-B also inhibited hydrolysis by both PLA2G1B and Group IIA sPLA2 (PLA2G2A). In films, PLA2G1B hydrolyzed surfactant PL monolayers at surface pressures ≤30 mN/m (P < 0.01), and SP-B lowered the surface pressure range at which hydrolysis can occur. These results suggest the hydrophobic SP, SP-B, protects alveolar surfactant PL from hydrolysis mediated by multiple sPLA(2) in both vesicles (alveolar subphase) and monomolecular films (air-liquid interface).

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22037357      PMCID: PMC3349360          DOI: 10.1152/ajplung.00054.2011

Source DB:  PubMed          Journal:  Am J Physiol Lung Cell Mol Physiol        ISSN: 1040-0605            Impact factor:   5.464


  53 in total

1.  The role of surfactant-associated proteins.

Authors:  F Possmayer
Journal:  Am Rev Respir Dis       Date:  1990-10

2.  The major lung surfactant protein, SP 28-36, is a calcium-dependent, carbohydrate-binding protein.

Authors:  H P Haagsman; S Hawgood; T Sargeant; D Buckley; R T White; K Drickamer; B J Benson
Journal:  J Biol Chem       Date:  1987-10-15       Impact factor: 5.157

3.  Cell-specific expression of group X and group V secretory phospholipases A(2) in human lung airway epithelial cells.

Authors:  M C Seeds; K A Jones; R Duncan Hite; M C Willingham; H M Borgerink; R D Woodruff; D L Bowton; D A Bass
Journal:  Am J Respir Cell Mol Biol       Date:  2000-07       Impact factor: 6.914

4.  Serial changes in surfactant-associated proteins in lung and serum before and after onset of ARDS.

Authors:  K E Greene; J R Wright; K P Steinberg; J T Ruzinski; E Caldwell; W B Wong; W Hull; J A Whitsett; T Akino; Y Kuroki; H Nagae; L D Hudson; T R Martin
Journal:  Am J Respir Crit Care Med       Date:  1999-12       Impact factor: 21.405

5.  Effect of reconstituted pulmonary surfactant containing the 6000-dalton hydrophobic protein on lung compliance of prematurely delivered rabbit fetuses.

Authors:  S H Yu; D Wallace; B Bhavnani; G Enhorning; P G Harding; F Possmayer
Journal:  Pediatr Res       Date:  1988-01       Impact factor: 3.756

6.  Pancreatic phospholipase A2: isolation of the human gene and cDNAs from porcine pancreas and human lung.

Authors:  J J Seilhamer; T L Randall; M Yamanaka; L K Johnson
Journal:  DNA       Date:  1986-12

7.  Binding of surfactant protein A (SP-A) to herpes simplex virus type 1-infected cells is mediated by the carbohydrate moiety of SP-A.

Authors:  J F van Iwaarden; J A van Strijp; H Visser; H P Haagsman; J Verhoef; L M van Golde
Journal:  J Biol Chem       Date:  1992-12-15       Impact factor: 5.157

8.  A mutation in the surfactant protein B gene responsible for fatal neonatal respiratory disease in multiple kindreds.

Authors:  L M Nogee; G Garnier; H C Dietz; L Singer; A M Murphy; D E deMello; H R Colten
Journal:  J Clin Invest       Date:  1994-04       Impact factor: 14.808

9.  Pulmonary surfactant protein A enhances the host-defense mechanism of rat alveolar macrophages.

Authors:  F van Iwaarden; B Welmers; J Verhoef; H P Haagsman; L M van Golde
Journal:  Am J Respir Cell Mol Biol       Date:  1990-01       Impact factor: 6.914

10.  Comparative studies on the biophysical activities of the low-molecular-weight hydrophobic proteins purified from bovine pulmonary surfactant.

Authors:  S H Yu; F Possmayer
Journal:  Biochim Biophys Acta       Date:  1988-08-12
View more
  7 in total

Review 1.  Meconium-induced inflammation and surfactant inactivation: specifics of molecular mechanisms.

Authors:  Jana Kopincova; Andrea Calkovska
Journal:  Pediatr Res       Date:  2015-12-17       Impact factor: 3.756

2.  IL-6 trans-signaling increases expression of airways disease genes in airway smooth muscle.

Authors:  Mac B Robinson; Deepak A Deshpande; Jeffery Chou; Wei Cui; Shelly Smith; Carl Langefeld; Annette T Hastie; Eugene R Bleecker; Gregory A Hawkins
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2015-05-22       Impact factor: 5.464

Review 3.  Group 1B phospholipase A2 in metabolic and inflammatory disease modulation.

Authors:  David Y Hui
Journal:  Biochim Biophys Acta Mol Cell Biol Lipids       Date:  2018-07-09       Impact factor: 4.698

4.  Clinical and biological role of secretory phospholipase A2 in acute respiratory distress syndrome infants.

Authors:  Daniele De Luca; Elena Lopez-Rodriguez; Angelo Minucci; Francesca Vendittelli; Leonarda Gentile; Eleonora Stival; Giorgio Conti; Marco Piastra; Massimo Antonelli; Mercedes Echaide; Jesus Perez-Gil; Ettore D Capoluongo
Journal:  Crit Care       Date:  2013-07-24       Impact factor: 9.097

5.  Synthetic lung surfactants containing SP-B and SP-C peptides plus novel phospholipase-resistant lipids or glycerophospholipids.

Authors:  Robert H Notter; Rohun Gupta; Adrian L Schwan; Zhengdong Wang; Mohanad Gh Shkoor; Frans J Walther
Journal:  PeerJ       Date:  2016-10-27       Impact factor: 2.984

6.  Porcine vs bovine surfactant therapy for preterm neonates with RDS: systematic review with biological plausibility and pragmatic meta-analysis of respiratory outcomes.

Authors:  Ascanio Tridente; Lucia De Martino; Daniele De Luca
Journal:  Respir Res       Date:  2019-02-06

Review 7.  Strategies to protect surfactant and enhance its activity.

Authors:  Daniele De Luca; Chiara Autilio
Journal:  Biomed J       Date:  2021-08-05       Impact factor: 4.910

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.